- Home
- Publications
- Publication Search
- Publication Details
Title
Exploiting Epigenetic Alterations in Prostate Cancer
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 18, Issue 5, Pages 1017
Publisher
MDPI AG
Online
2017-05-09
DOI
10.3390/ijms18051017
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chemical probes targeting epigenetic proteins: Applications beyond oncology
- (2017) Suzanne Ackloo et al. Epigenetics
- Global Burden of Urologic Cancers, 1990–2013
- (2017) Geolani W. Dy et al. EUROPEAN UROLOGY
- Benzoisoquinolinediones as Potent and Selective Inhibitors of BRPF2 and TAF1/TAF1L Bromodomains
- (2017) Léa Bouché et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of First-in-Class, Potent, and Orally Bioavailable Embryonic Ectoderm Development (EED) Inhibitor with Robust Anticancer Efficacy
- (2017) Ying Huang et al. JOURNAL OF MEDICINAL CHEMISTRY
- The importance of DNA methylation in prostate cancer development
- (2017) Charles E. Massie et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancer
- (2017) Di Zhao et al. NATURE
- An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED
- (2017) Wei Qi et al. Nature Chemical Biology
- The EED protein–protein interaction inhibitor A-395 inactivates the PRC2 complex
- (2017) Yupeng He et al. Nature Chemical Biology
- MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
- (2017) Rajesha Rupaimoole et al. NATURE REVIEWS DRUG DISCOVERY
- C-Met/miR-130b axis as novel mechanism and biomarker for castration resistance state acquisition
- (2017) A Cannistraci et al. ONCOGENE
- MicroRNA-455-3p functions as a tumor suppressor by targeting eIF4E in prostate cancer
- (2017) Yongxiang Zhao et al. ONCOLOGY REPORTS
- Targeted protein degradation by PROTACs
- (2017) Taavi K. Neklesa et al. PHARMACOLOGY & THERAPEUTICS
- Recent scenario of microRNA as diagnostic and prognostic biomarkers of prostate cancer
- (2017) Kamla Kant Shukla et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Proteasome-associated deubiquitinase ubiquitin-specific protease 14 regulates prostate cancer proliferation by deubiquitinating and stabilizing androgen receptor
- (2017) Yuning Liao et al. Cell Death & Disease
- Targeting Cancer Cells with BET Bromodomain Inhibitors
- (2017) Yali Xu et al. Cold Spring Harbor Perspectives in Medicine
- Epigenomic Regulation of Androgen Receptor Signaling: Potential Role in Prostate Cancer Therapy
- (2017) Vito Cucchiara et al. Cancers
- Discovery and Molecular Basis of a Diverse Set of Polycomb Repressive Complex 2 Inhibitors Recognition by EED
- (2017) Ling Li et al. PLoS One
- Targeting cancer using KAT inhibitors to mimic lethal knockouts
- (2016) J. A. L. Brown et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Modulation of p300/CBP Acetylation of Nucleosomes by Bromodomain Ligand I-CBP112
- (2016) Beth E. Zucconi et al. BIOCHEMISTRY
- Immunotherapy for prostate cancer: False promises or true hope?
- (2016) Brian T. Rekoske et al. CANCER
- TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer
- (2016) Anna C. Groner et al. CANCER CELL
- Loss of CHD1 causes DNA repair defects and enhances prostate cancer therapeutic responsiveness
- (2016) Vijayalakshmi Kari et al. EMBO REPORTS
- Phase I and II therapies targeting the androgen receptor for the treatment of castration resistant prostate cancer
- (2016) Athanasios Dellis et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Targeting epigenetic regulators for cancer therapy: modulation of bromodomain proteins, methyltransferases, demethylases, and microRNAs
- (2016) Kathy A. Gelato et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- The Bromodomain and Extra-Terminal Domain (BET) Family: Functional Anatomy of BET Paralogous Proteins
- (2016) Yasushi Taniguchi INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Reducible self-assembling cationic polypeptide-based micelles mediate co-delivery of doxorubicin and microRNA-34a for androgen-independent prostate cancer therapy
- (2016) Chong Yao et al. JOURNAL OF CONTROLLED RELEASE
- The roles of microRNAs in the progression of castration-resistant prostate cancer
- (2016) Satoko Kojima et al. JOURNAL OF HUMAN GENETICS
- The molecular underpinnings of prostate cancer: impacts on management and pathology practice
- (2016) Daniel Nava Rodrigues et al. JOURNAL OF PATHOLOGY
- Prostate cancer
- (2016) Gerhardt Attard et al. LANCET
- BET Bromodomain Inhibitors Enhance Efficacy and Disrupt Resistance to AR Antagonists in the Treatment of Prostate Cancer
- (2016) I. A. Asangani et al. MOLECULAR CANCER RESEARCH
- Exploitation of Castration-Resistant Prostate Cancer Transcription Factor Dependencies by the Novel BET Inhibitor ABBV-075
- (2016) Emily J. Faivre et al. MOLECULAR CANCER RESEARCH
- KAT8 Regulates Androgen Signaling in Prostate Cancer Cells
- (2016) Ji-Young Kim et al. MOLECULAR ENDOCRINOLOGY
- Translational and clinical implications of the genetic landscape of prostate cancer
- (2016) Daniel E. Spratt et al. Nature Reviews Clinical Oncology
- Drug discovery in advanced prostate cancer: translating biology into therapy
- (2016) Timothy A. Yap et al. NATURE REVIEWS DRUG DISCOVERY
- Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
- (2016) Colin C. Pritchard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Protein arginine methyltransferase 5 functions as an epigenetic activator of the androgen receptor to promote prostate cancer cell growth
- (2016) X Deng et al. ONCOGENE
- PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer
- (2016) Kanak Raina et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- P110β Inhibition Reduces Histone H3K4 Di-Methylation in Prostate Cancer
- (2016) Jun Pang et al. PROSTATE
- Novel and next-generation androgen receptor–directed therapies for prostate cancer: Beyond abiraterone and enzalutamide
- (2016) Richard M. Bambury et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Combination effect of therapies targeting the PI3K- and AR-signaling pathways in prostate cancer
- (2016) Shalini Singh Yadav et al. Oncotarget
- BET bromodomain-mediated interaction between ERG and BRD4 promotes prostate cancer cell invasion
- (2016) Alexandra M. Blee et al. Oncotarget
- Cellular androgen content influences enzalutamide agonism of F877L mutant androgen receptor
- (2016) Daniel J. Coleman et al. Oncotarget
- Histone demethylase lysine demethylase 5B in development and cancer
- (2016) Mengjiao Han et al. Oncotarget
- Genomic and epigenomic analysis of high-risk prostate cancer reveals changes in hydroxymethylation and TET1
- (2016) Lien Spans et al. Oncotarget
- c-MYC drives histone demethylase PHF8 during neuroendocrine differentiation and in castration-resistant prostate cancer
- (2016) Peterson Kariuki Maina et al. Oncotarget
- Targeting BET bromodomain proteins in solid tumors
- (2016) Vaibhav Sahai et al. Oncotarget
- Oncogenic microRNA-4534 regulates PTEN pathway in prostate cancer
- (2016) Hannah Nip et al. Oncotarget
- Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer
- (2016) Narsis Attar et al. Cold Spring Harbor Perspectives in Medicine
- Epigenetic modulators as therapeutic targets in prostate cancer
- (2016) Inês Graça et al. Clinical Epigenetics
- ERG signaling in prostate cancer is driven through PRMT5-dependent methylation of the Androgen Receptor
- (2016) Zineb Mounir et al. eLife
- The HIF/PHF8/AR axis promotes prostate cancer progression
- (2016) D Tong et al. Oncogenesis
- The genomic evolution of human prostate cancer
- (2015) T Mitchell et al. BRITISH JOURNAL OF CANCER
- miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src
- (2015) X.-B. Shi et al. CANCER RESEARCH
- Coordinate Loss of MAP3K7 and CHD1 Promotes Aggressive Prostate Cancer
- (2015) L. U. Rodrigues et al. CANCER RESEARCH
- miR-145 suppress the androgen receptor in prostate cancer cells and correlates to prostate cancer prognosis
- (2015) Olivia Larne et al. CARCINOGENESIS
- Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters
- (2015) Nathaniel Melling et al. CARCINOGENESIS
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- The Molecular Taxonomy of Primary Prostate Cancer
- (2015) Adam Abeshouse et al. CELL
- The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond
- (2015) Nicole Stopa et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Phase I/II Study of Azacitidine, Docetaxel, and Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Therapy
- (2015) Rakesh Singal et al. Clinical Genitourinary Cancer
- Implications of ubiquitin ligases in castration-resistant prostate cancer
- (2015) Jianfei Qi et al. CURRENT OPINION IN ONCOLOGY
- A phase II study of the HDAC inhibitor SB939 in patients with castration resistant prostate cancer: NCIC clinical trials group study IND195
- (2015) B. J. Eigl et al. INVESTIGATIONAL NEW DRUGS
- The Deubiquitinating Enzyme USP7 Regulates Androgen Receptor Activity by Modulating Its Binding to Chromatin
- (2015) Shu-Ting Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Androgen Receptor Coactivators in Regulation of Growth and Differentiation in Prostate Cancer
- (2015) Zoran Culig JOURNAL OF CELLULAR PHYSIOLOGY
- A SMYD3 Small-Molecule Inhibitor Impairing Cancer Cell Growth
- (2015) Alessia Peserico et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Discovery of a Chemical Tool Inhibitor Targeting the Bromodomains of TRIM24 and BRPF
- (2015) James Bennett et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure-Guided Design of IACS-9571, a Selective High-Affinity Dual TRIM24-BRPF1 Bromodomain Inhibitor
- (2015) Wylie S. Palmer et al. JOURNAL OF MEDICINAL CHEMISTRY
- The evolutionary history of lethal metastatic prostate cancer
- (2015) Gunes Gundem et al. NATURE
- Targeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapies
- (2015) Siu Chiu Chan et al. NUCLEIC ACIDS RESEARCH
- HDAC inhibition impedes epithelial–mesenchymal plasticity and suppresses metastatic, castration-resistant prostate cancer
- (2015) M Ruscetti et al. ONCOGENE
- Targeting BET bromodomains for cancer treatment
- (2015) Marie Jung et al. Epigenomics
- Microdissecting the role of microRNAs in the pathogenesis of prostate cancer
- (2015) Shiekh Gazalla Ayub et al. Cancer Genetics
- SMYD3 contributes to a more aggressive phenotype of prostate cancer and targets Cyclin D2 through H4K20me3
- (2015) Filipa Quintela Vieira et al. Oncotarget
- NCL1, a highly selective lysine-specific demethylase 1 inhibitor, suppresses prostate cancer without adverse effect
- (2015) Toshiki Etani et al. Oncotarget
- Inhibition of BET bromodomain proteins as a therapeutic approach in prostate cancer.
- (2015) Anastasia Wyce et al. Oncotarget
- Demethylation of the miR-146a promoter by 5-Aza-2’-deoxycytidine correlates with delayed progression of castration-resistant prostate cancer
- (2014) Xiaolu Wang et al. BMC CANCER
- DNA methylation status is more reliable than gene expression at detecting cancer in prostate biopsy
- (2014) A Paziewska et al. BRITISH JOURNAL OF CANCER
- BET bromodomain inhibitors—A novel epigenetic approach in castration-resistant prostate cancer
- (2014) Sarah E Lochrin et al. CANCER BIOLOGY & THERAPY
- Androgen Receptor Is the Key Transcriptional Mediator of the Tumor Suppressor SPOP in Prostate Cancer
- (2014) C. Geng et al. CANCER RESEARCH
- The convergence of DNA damage checkpoint pathways and androgen receptor signaling in prostate cancer
- (2014) H. Q. Ta et al. ENDOCRINE-RELATED CANCER
- A Role for WDR5 in Integrating Threonine 11 Phosphorylation to Lysine 4 Methylation on Histone H3 during Androgen Signaling and in Prostate Cancer
- (2014) Ji-Young Kim et al. MOLECULAR CELL
- Coactivator MYST1 Regulates Nuclear Factor-κB and Androgen Receptor Functions During Proliferation of Prostate Cancer Cells
- (2014) Anbalagan Jaganathan et al. MOLECULAR ENDOCRINOLOGY
- Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer
- (2014) Irfan A. Asangani et al. NATURE
- Three-tiered role of the pioneer factor GATA2 in promoting androgen-dependent gene expression in prostate cancer
- (2014) Dayong Wu et al. NUCLEIC ACIDS RESEARCH
- Novel Epigenetic Target Therapy for Prostate Cancer: A Preclinical Study
- (2014) Ilaria Naldi et al. PLoS One
- Global DNA hypomethylation in prostate cancer development and progression: a systematic review
- (2014) R Zelic et al. PROSTATE CANCER AND PROSTATIC DISEASES
- An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element
- (2014) M. R. Mansour et al. SCIENCE
- Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer
- (2014) J.-P. P. Theurillat et al. SCIENCE
- Connections between TET proteins and aberrant DNA modification in cancer
- (2014) Yun Huang et al. TRENDS IN GENETICS
- Epigenetic modifications in prostate cancer
- (2014) Marjolaine Ngollo et al. Epigenomics
- Intratumor DNA Methylation Heterogeneity Reflects Clonal Evolution in Aggressive Prostate Cancer
- (2014) David Brocks et al. Cell Reports
- A phase 2 study of intravenous panobinostat in patients with castration-resistant prostate cancer
- (2013) Dana E. Rathkopf et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Multifaceted role of EZH2 in breast and prostate tumorigenesis
- (2013) Gauri Deb et al. Epigenetics
- SMYD3 as an Oncogenic Driver in Prostate Cancer by Stimulation of Androgen Receptor Transcription
- (2013) Cheng Liu et al. JNCI-Journal of the National Cancer Institute
- The lysine specific demethylase-1 (LSD1/KDM1A) regulates VEGF-A expression in prostate cancer
- (2013) Vasundhra Kashyap et al. Molecular Oncology
- The lysine demethylase, KDM4B, is a key molecule in androgen receptor signalling and turnover
- (2013) Kelly Coffey et al. NUCLEIC ACIDS RESEARCH
- Panobinostat synergizes with zoledronic acid in prostate cancer and multiple myeloma models by increasing ROS and modulating mevalonate and p38-MAPK pathways
- (2013) F Bruzzese et al. Cell Death & Disease
- EZH2, an epigenetic driver of prostate cancer
- (2013) Yeqing Angela Yang et al. Protein & Cell
- Transcription, DNA Damage and Beyond: The Roles of Histone Ubiquitination and Deubiquitination
- (2012) Hai-Ning Du CURRENT PROTEIN & PEPTIDE SCIENCE
- The enigmatic role of H2Bub1 in cancer
- (2012) Steven A. Johnsen FEBS LETTERS
- Regulation of the androgen receptor by post-translational modifications
- (2012) Kelly Coffey et al. JOURNAL OF ENDOCRINOLOGY
- Discovery and Characterization of NK13650s, Naturally Occurring p300-Selective Histone Acetyltransferase Inhibitors
- (2012) Shigehiro Tohyama et al. JOURNAL OF ORGANIC CHEMISTRY
- The mutational landscape of lethal castration-resistant prostate cancer
- (2012) Catherine S. Grasso et al. NATURE
- Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
- (2012) Christopher E Barbieri et al. NATURE GENETICS
- Increased levels of DNA methyltransferases are associated with the tumorigenic capacity of prostate cancer cells
- (2012) GIOVANNI LUCA GRAVINA et al. ONCOLOGY REPORTS
- Lestaurtinib Inhibits Histone Phosphorylation and Androgen-Dependent Gene Expression in Prostate Cancer Cells
- (2012) Jens Köhler et al. PLoS One
- Characterisation of a Tip60 Specific Inhibitor, NU9056, in Prostate Cancer
- (2012) Kelly Coffey et al. PLoS One
- Alterations of global histone H4K20 methylation during prostate carcinogenesis
- (2012) Turang E Behbahani et al. BMC Urology
- Histone Ubiquitination and Deubiquitination in Transcription, DNA Damage Response, and Cancer
- (2012) Jian Cao et al. Frontiers in Oncology
- Androgen Receptor Gene Expression in Prostate Cancer Is Directly Suppressed by the Androgen Receptor Through Recruitment of Lysine-Specific Demethylase 1
- (2011) Changmeng Cai et al. CANCER CELL
- Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer Cells
- (2011) P. Ostling et al. CANCER RESEARCH
- Hormonal Therapy Promotes Hormone-Resistant Phenotype by Increasing DNMT Activity and Expression in Prostate Cancer Models
- (2011) Giovanni Luca Gravina et al. ENDOCRINOLOGY
- Selective Roles for cAMP Response Element-binding Protein Binding Protein and p300 Protein as Coregulators for Androgen-regulated Gene Expression in Advanced Prostate Cancer Cells
- (2011) Irina Ianculescu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Histone demethylation and steroid receptor function in cancer
- (2011) Antje Stratmann et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Histone H2B ubiquitin ligases RNF20 and RNF40 in androgen signaling and prostate cancer cell growth
- (2011) Tiina Jääskeläinen et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancer
- (2011) Francesco Crea et al. Molecular Cancer
- Inhibition of the Acetyltransferases p300 and CBP Reveals a Targetable Function for p300 in the Survival and Invasion Pathways of Prostate Cancer Cell Lines
- (2011) F. R. Santer et al. MOLECULAR CANCER THERAPEUTICS
- USP10 deubiquitylates the histone variant H2A.Z and both are required for androgen receptor-mediated gene activation
- (2011) Ryan Draker et al. NUCLEIC ACIDS RESEARCH
- Recurrent deletion of CHD1 in prostate cancer with relevance to cell invasiveness
- (2011) S Huang et al. ONCOGENE
- Systematic knockdown of epigenetic enzymes identifies a novel histone demethylase PHF8 overexpressed in prostate cancer with an impact on cell proliferation, migration and invasion
- (2011) M Björkman et al. ONCOGENE
- EZH2and cancer stem cells: fact or fiction?
- (2011) Francesco Crea Epigenomics
- An Integrated Network of Androgen Receptor, Polycomb, and TMPRSS2-ERG Gene Fusions in Prostate Cancer Progression
- (2010) Jindan Yu et al. CANCER CELL
- Global Levels of Specific Histone Modifications and an Epigenetic Gene Signature Predict Prostate Cancer Progression and Development
- (2010) T. Bianco-Miotto et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Androgen Receptor Signalling in Prostate Cancer: The Functional Consequences of Acetylation
- (2010) Derek N. Lavery et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- TAF1 Differentially Enhances Androgen Receptor Transcriptional Activity via Its N-Terminal Kinase and Ubiquitin-Activating and -Conjugating Domains
- (2010) Peyman Tavassoli et al. MOLECULAR ENDOCRINOLOGY
- 5-azacitidine restores and amplifies the bicalutamide response on preclinical models of androgen receptor expressing or deficient prostate tumors
- (2010) Giovanni Luca Gravina et al. PROSTATE
- Phase II, two-stage, single-arm trial of the histone deacetylase inhibitor (HDACi) romidepsin in metastatic castration-resistant prostate cancer (CRPC)
- (2009) L. R. Molife et al. ANNALS OF ONCOLOGY
- Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker
- (2009) P N Munster et al. BRITISH JOURNAL OF CANCER
- Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862)
- (2009) Deborah Bradley et al. CANCER
- Androgen-Induced Coactivator ANCCA Mediates Specific Androgen Receptor Signaling in Prostate Cancer
- (2009) J. X. Zou et al. CANCER RESEARCH
- Histone Deacetylases Are Required for Androgen Receptor Function in Hormone-Sensitive and Castrate-Resistant Prostate Cancer
- (2009) D. S. Welsbie et al. CANCER RESEARCH
- Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models
- (2009) Claudio Festuccia et al. ENDOCRINE-RELATED CANCER
- Tip60 promotes prostate cancer cell proliferation by translocation of androgen receptor into the nucleus
- (2009) Masaki Shiota et al. PROSTATE
- Global levels of histone modifications predict prostate cancer recurrence
- (2009) Jörg Ellinger et al. PROSTATE
- Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy
- (2008) W Weichert et al. BRITISH JOURNAL OF CANCER
- Defining the molecular action of HDAC inhibitors and synergism with androgen deprivation in ERG-positive prostate cancer
- (2008) Mari Björkman et al. INTERNATIONAL JOURNAL OF CANCER
- Phase II Trial of Docetaxel With Rapid Androgen Cycling for Progressive Noncastrate Prostate Cancer
- (2008) Dana Rathkopf et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic Androgen Receptor-Occupied Regions with Different Functions, Defined by Histone Acetylation, Coregulators and Transcriptional Capacity
- (2008) Li Jia et al. PLoS One
- Circulating microRNAs as stable blood-based markers for cancer detection
- (2008) P. S. Mitchell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Androgen receptor acetylation sites differentially regulate gene control
- (2007) Hortensia Faus et al. JOURNAL OF CELLULAR BIOCHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started